Who funds cancer metastasis research?
We count 103 funded cancer metastasis projects, active between 2020 and 2032, from 5 funders. The most came from EU · ERC (50 projects), EU · MSCA (28 projects) and EU · EIC (8 projects). The median award is $2.1M, across the 99 of 103 projects that list an amount.
- Funded projects
- 103
- Funders
- 5
- Median award
- $2.1M
- Open calls now
- 1
Top funders of cancer metastasis research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| EU · ERC | 50 | 49% | $2.1M |
| EU · MSCA | 28 | 27% | $281K |
| EU · EIC | 8 | 8% | $3M |
| Wellcome | 5 | 5% | — |
| EU · Health | 4 | 4% | $7.1M |
| UKRI · UKRI FLF | 3 | 3% | $754K |
| NIH · NCI | 2 | 2% | — |
| NSF · MPS | 2 | 2% | — |
| NIH · NHLBI | 1 | 1% | — |
Projects whose title or summary mentions cancer metastasis. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open cancer metastasis funding calls
1 open call mentions cancer metastasis today.
-
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
National Institutes of HealthUp to $500,000Deadline: November 22, 2028 ·
Funded cancer metastasis projects
A sample, latest start first, at most three per program.
-
Targeting tumour-promoting malignant cell-fibroblast crosstalk in pancreatic cancer
UKRI · UKRI FLF · £595,566 · ends 2030
-
FDT-BioTech: Theranostic Digital Twins for Personalized Cancer Treatment
NSF · MPS · $558,159 · ends 2029
-
Understanding Mesenchymal Tissue Mechanics via Nanorobotics
Wellcome · £759,644 · ends 2029
-
Human Tumor Atlas Network: Data Coordinating Center
NIH · NCI · $8,850,407 · ends 2029
-
Human Prostate Tumor Atlas Center
NIH · NCI · $4,130,083 · ends 2029
-
Inferring and Modeling Excitable Dynamics in Cell Migration
NSF · MPS · $300,000 · ends 2028
-
Phosphoinositide signalling as a regulator of tumour growth and metastasis
UKRI · UKRI FLF · £593,674 · ends 2028
-
Exploring Allostery at the Atypical Chemokine Receptor 3 (ACKR3)
Wellcome · ends 2028
-
Novel imaging strategies to investigate 3D tumour invasion at the molecular level - renewal
UKRI · UKRI FLF · £594,307 · ends 2027
-
Poor Prognosis Colorectal Cancers Display Self-sustained Growth by Niche-mimicry
EU · ERC · €1,949,358 · ends 2027
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “metastasis or metastatic”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with cancer metastasis calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free